tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nanobiotix’s NBTXR3: Promising Survival Benefits and Strategic Collaborations Justify Buy Rating
PremiumRatingsNanobiotix’s NBTXR3: Promising Survival Benefits and Strategic Collaborations Justify Buy Rating
4M ago
Nanobiotix SA’s Positive Earnings Call Highlights Strategic Growth
Premium
Company Announcements
Nanobiotix SA’s Positive Earnings Call Highlights Strategic Growth
5M ago
Nanobiotix price target lowered to $8 from $12 at Guggenheim
Premium
The Fly
Nanobiotix price target lowered to $8 from $12 at Guggenheim
5M ago
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
PremiumRatingsNanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
6M ago
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
Premium
Ratings
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
6M ago
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
Premium
The Fly
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
6M ago
Nanobiotix completes dose escalation-expansion parts  of NBTXR3  in PC
PremiumThe FlyNanobiotix completes dose escalation-expansion parts of NBTXR3 in PC
9M ago
Nanobiotix initiated with a Buy at Guggenheim
Premium
The Fly
Nanobiotix initiated with a Buy at Guggenheim
1y ago
Nanobiotix initiated with a Buy at Guggenheim
Premium
The Fly
Nanobiotix initiated with a Buy at Guggenheim
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100